IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.
about
Cardiac cachexia: hic et nuncInflammation based regulation of cancer cachexiaCachectic skeletal muscle response to a novel bout of low-frequency stimulationSex differences in the relationship of IL-6 signaling to cancer cachexia progressionInhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexiaPreserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia.Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexiaDifferential Bone Loss in Mouse Models of Colon Cancer Cachexia.Eccentric contraction-induced myofiber growth in tumor-bearing mice.Combination of exercise training and erythropoietin prevents cancer-induced muscle alterationsThe emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingPseudouridine synthase 1 deficient mice, a model for Mitochondrial Myopathy with Sideroblastic Anemia, exhibit muscle morphology and physiology alterations.Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle.Identification of STOML2 as a putative novel asthma risk gene associated with IL6R.TWEAK promotes exercise intolerance by decreasing skeletal muscle oxidative phosphorylation capacity.Hemorrhagic shock and resuscitation are associated with peripheral blood mononuclear cell mitochondrial dysfunction and immunosuppression.Regulation of muscle protein synthesis and the effects of catabolic states.Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia.Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.Role of interleukin-6 in cachexia: therapeutic implications.Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection.Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.Novel investigational drugs mimicking exercise for the treatment of cachexia.Mitochondrial network regulation and its potential interference with inflammatory signals in pancreatic beta cells.Understanding tumor anabolism and patient catabolism in cancer-associated cachexiaLong-term exercise training prevents mammary tumorigenesis-induced muscle wasting in rats through the regulation of TWEAK signalling.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia.Effect of conjugated linoleic acids and omega-3 fatty acids with or without resistance training on muscle mass in high-fat diet-fed middle-aged mice.Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy.Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.Inflammatory signalling regulates eccentric contraction-induced protein synthesis in cachectic skeletal muscle.Skeletal Muscle Function During the Progression of Cancer Cachexia in the Male ApcMin/+ Mouse.Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.The Role of gp130 in Basal and Exercise Trained Skeletal Muscle Mitochondrial Quality Control.Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.Resveratrol Improves Muscle Atrophy by Modulating Mitochondrial Quality Control in STZ-Induced Diabetic Mice.
P2860
Q26744140-AF6E2FD0-BD19-4BCE-9EB6-39F3055A9673Q33615916-1D693AAA-8A05-4DBD-9250-C101F7DB34F4Q33673314-EC59EFC6-59F4-443B-A6E4-E861D47AE947Q35214154-19EFE02B-8658-4996-8E18-C2570965CA07Q35536351-C9CA04D3-14CC-44F5-ABF3-326C104B1C09Q35690207-B1559F47-9D0E-4DC9-AB7E-4FA80142D1E6Q35958613-430C0D5A-BB7B-453A-B7F0-F0D3CFDF4942Q36260536-6A3AA989-B5F7-4FBE-8E71-C8964758FCD1Q36422662-EAA08199-7772-4790-ACC4-6991D121E659Q36685366-5A4D7129-02DA-4DE3-8FA0-64E0A410936AQ36901945-3CB79783-3C43-42D2-B920-1429ADBD6353Q36919088-6832F18B-04DD-4019-B677-FC7E58C842D8Q36941459-D77BB388-AC60-45C3-89DB-F0AFDD60A520Q37004125-C5704466-31E1-43F1-99C8-05D996ABEAF1Q37014194-CA7CBEBE-642C-43D9-8845-7E59D3136918Q37097326-651C652F-32B3-4557-938A-F9CF98B95850Q37138209-0FBCD945-BADA-400A-A6EB-C7D7EF11967FQ37392800-94FD72A8-6EE9-44B1-BC6E-D255264D88B3Q37503704-47CAA9A6-8B2A-4AE3-90F9-7CE6138846D6Q37644886-CADC1150-600A-47A1-9240-7DF27CB1EBA8Q38260561-8E074FE9-CF12-479C-A953-41BA13DD3608Q38404732-39BF8728-D99C-4A74-B6D8-6AFCEBE0471CQ38606110-6A1F5E0A-7084-46EC-AB68-9C96CFA98A6FQ38631222-24F48C83-EBAF-446A-8DD3-DC3BD5EE3F6FQ38731873-5881A2D5-A1B2-4378-B79B-21E4CBA4A347Q39339489-8F48ABF2-AEAF-47D8-8F89-7E13D880572DQ39733891-EEAA0318-B37E-4C03-915A-CA33F0098A65Q41146515-11E63E82-108C-45A7-90FC-A1C1DC348744Q41613604-D9F04491-816A-403B-8470-4E8A82309585Q42376081-D0AF90B8-B59F-40DA-A0F6-DC21E3615327Q46154742-06538C8C-5339-4005-92FD-0F45F8F56CA6Q46600489-5791CDDE-E6A1-41A4-9266-40938B8DDDB5Q47130400-58A7F86E-D852-4E46-980F-840F4CFCC14CQ47320394-05C56A43-920F-4FA9-831D-CBDD6ED68679Q47419257-E69CE04B-1ECC-4632-866C-413D5A2DD9D1Q47979117-5DDCC02D-CDF7-4E9A-9BFC-B94FCC91A54CQ48155681-FB69634E-FADE-4210-B5E7-DE76D7CBCA2AQ49495536-80B9AB05-EA45-46EE-8B9F-5D1094E8227CQ51033534-1B619606-9713-4C51-872C-D100B48CE712Q55266104-0446EC4C-5881-4751-8523-0EAC2A96A257
P2860
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
IL-6 regulation on skeletal mu ...... achexia in the ApcMin/+ mouse.
@ast
IL-6 regulation on skeletal mu ...... achexia in the ApcMin/+ mouse.
@en
type
label
IL-6 regulation on skeletal mu ...... achexia in the ApcMin/+ mouse.
@ast
IL-6 regulation on skeletal mu ...... achexia in the ApcMin/+ mouse.
@en
prefLabel
IL-6 regulation on skeletal mu ...... achexia in the ApcMin/+ mouse.
@ast
IL-6 regulation on skeletal mu ...... achexia in the ApcMin/+ mouse.
@en
P2093
P2860
P356
P1433
P1476
IL-6 regulation on skeletal mu ...... cachexia in the ApcMin/+ mouse
@en
P2093
James P White
John W Baynes
Lydia E Matesic
Matthew C Kostek
Melissa J Puppa
Robert L Price
Shuichi Sato
P2860
P2888
P356
10.1186/2044-5040-2-14
P577
2012-07-06T00:00:00Z
P5875
P6179
1024510684